NO984245L - Nasal administrasjon av midler for behandling av emesis med forsinket begynnelse - Google Patents

Nasal administrasjon av midler for behandling av emesis med forsinket begynnelse

Info

Publication number
NO984245L
NO984245L NO984245A NO984245A NO984245L NO 984245 L NO984245 L NO 984245L NO 984245 A NO984245 A NO 984245A NO 984245 A NO984245 A NO 984245A NO 984245 L NO984245 L NO 984245L
Authority
NO
Norway
Prior art keywords
agents
treatment
nasal administration
late onset
onset emesis
Prior art date
Application number
NO984245A
Other languages
English (en)
Norwegian (no)
Other versions
NO984245D0 (no
Inventor
Mary Psilogenis
Original Assignee
Ribogene Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ribogene Inc filed Critical Ribogene Inc
Publication of NO984245D0 publication Critical patent/NO984245D0/no
Publication of NO984245L publication Critical patent/NO984245L/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • A61K31/165Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0043Nose
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • A61K31/165Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/166Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the carbon of a carboxamide group directly attached to the aromatic ring, e.g. procainamide, procarbazine, metoclopramide, labetalol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Otolaryngology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hospice & Palliative Care (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
NO984245A 1996-03-14 1998-09-14 Nasal administrasjon av midler for behandling av emesis med forsinket begynnelse NO984245L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/616,121 US5760086A (en) 1996-03-14 1996-03-14 Nasal administration of agents for treatment of delayed onset emesis
PCT/US1997/003974 WO1997033573A1 (en) 1996-03-14 1997-03-13 Nasal administration of agents for treatment of delayed onset emesis

Publications (2)

Publication Number Publication Date
NO984245D0 NO984245D0 (no) 1998-09-14
NO984245L true NO984245L (no) 1998-11-11

Family

ID=24468120

Family Applications (1)

Application Number Title Priority Date Filing Date
NO984245A NO984245L (no) 1996-03-14 1998-09-14 Nasal administrasjon av midler for behandling av emesis med forsinket begynnelse

Country Status (24)

Country Link
US (1) US5760086A (da)
EP (1) EP0891186B1 (da)
JP (1) JP2000507234A (da)
KR (1) KR100420673B1 (da)
CN (1) CN1217657A (da)
AT (1) ATE489137T1 (da)
AU (1) AU707467B2 (da)
BG (1) BG102780A (da)
CA (1) CA2248968C (da)
CZ (1) CZ289797B6 (da)
DE (1) DE69740060D1 (da)
DK (1) DK0891186T3 (da)
EE (1) EE03665B1 (da)
ES (1) ES2357520T3 (da)
IL (1) IL126199A (da)
NO (1) NO984245L (da)
NZ (1) NZ331991A (da)
PL (1) PL328940A1 (da)
PT (1) PT891186E (da)
RU (1) RU2181588C2 (da)
SK (1) SK282695B6 (da)
UA (1) UA57733C2 (da)
WO (1) WO1997033573A1 (da)
YU (1) YU40398A (da)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6770262B2 (en) * 2000-03-30 2004-08-03 Questcor Pharmaceuticals, Inc. Nasal administration of agents for the treatment of gastroparesis
PL2343987T3 (pl) * 2008-11-11 2013-05-31 Unilever Nv Herbaciana kompozycja
PL2376075T3 (pl) * 2008-12-22 2015-08-31 Evoke Pharma Inc Donosowe preparaty z metoklopramidu
US20130213393A1 (en) 2009-12-22 2013-08-22 Evoke Pharma, Inc. Nasal formulations of metoclopramide
US20110165143A1 (en) * 2010-01-06 2011-07-07 The Regents Of The University Of Colorado, A Body Corporate Modulation of caspases and therapeutical applications
CN103957707A (zh) 2011-08-25 2014-07-30 伊沃克制药公司 与女性胃轻瘫有关的症状的治疗
FR2980976B1 (fr) * 2011-10-10 2015-10-16 Mohamed Skiba Composition pharmaceutique pour l'administration par voie nasale de la metopimazine
CN104606136A (zh) * 2015-01-06 2015-05-13 中国人民解放军军事医学科学院毒物药物研究所 甲氧氯普胺鼻腔喷雾剂、其制备方法及用途
US11517545B2 (en) 2016-12-15 2022-12-06 Evoke Pharma, Inc. Treatment of moderate and severe gastroparesis

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4624965A (en) * 1984-11-15 1986-11-25 Nastech Pharmaceutical Co., Inc. Novel method of administering anti-nausea and anti-emetic pharmaceutical agents and novel dosage forms containing same

Also Published As

Publication number Publication date
BG102780A (en) 2000-01-31
UA57733C2 (uk) 2003-07-15
EE9800295A (et) 1999-02-15
NO984245D0 (no) 1998-09-14
PT891186E (pt) 2011-02-25
SK282695B6 (sk) 2002-11-06
CZ289797B6 (cs) 2002-04-17
SK125998A3 (en) 1999-03-12
US5760086A (en) 1998-06-02
AU707467B2 (en) 1999-07-08
WO1997033573A1 (en) 1997-09-18
IL126199A (en) 2004-06-01
DE69740060D1 (de) 2011-01-05
KR100420673B1 (ko) 2004-07-23
NZ331991A (en) 2000-04-28
EP0891186A1 (en) 1999-01-20
EP0891186A4 (en) 2004-03-31
PL328940A1 (en) 1999-03-01
CA2248968C (en) 2005-08-02
IL126199A0 (en) 1999-05-09
RU2181588C2 (ru) 2002-04-27
CN1217657A (zh) 1999-05-26
JP2000507234A (ja) 2000-06-13
ATE489137T1 (de) 2010-12-15
CZ292298A3 (cs) 1999-03-17
KR19990087763A (ko) 1999-12-27
EP0891186B1 (en) 2010-11-24
ES2357520T3 (es) 2011-04-27
AU2210297A (en) 1997-10-01
DK0891186T3 (da) 2011-03-14
CA2248968A1 (en) 1997-09-18
EE03665B1 (et) 2002-04-15
YU40398A (sh) 2001-07-10

Similar Documents

Publication Publication Date Title
CY1111396T1 (el) Ρινικη χορηγηση μετοκλοπραμιδης για την αγωγη της γαστροπαρεσης
DE69926806D1 (de) N-ureidoalkylpiperidine als modulatoren der aktivität der chemokinrezeptoren
IL147184A0 (en) Substituted benzimidazole
DE69926919D1 (de) N-ureidoalkylpiperidine als modulatoren der aktivität der chemokinrezeptoren
IL110943A (en) Compositions comprising an inhibitor of cholesterol synthesis for the treatment of skin disorders
SE9502893L (sv) Användning av kollagenas
NO984245D0 (no) Nasal administrasjon av midler for behandling av emesis med forsinket begynnelse
EP0992243A4 (en) PROPHYLACTIC / THERAPEUTIC AGENT
DE69230224D1 (de) Potenzierung von nmda-antagonisten
DK0845988T3 (da) Hidtil ukendte kondenserede isoquinoliner som dopaminreceptorligander
ATE330604T1 (de) Behandlung von manischen erkrankungen
TW366338B (en) Arylalkoxyphenoxy-imidazoline compounds
NO954115L (no) Anvendelse av ceruletid-dietylaminsalt ved behandling av psoriasis
KR970020846U (ko) 근골격계질환 치료보조용 반창고

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application